# Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS)

> **NCT04048434** · NA · UNKNOWN · sponsor: **Hannover Medical School** · enrollment: 34 (estimated)

## Conditions studied

- Cytokine Release Syndrome
- CAR-T

## Interventions

- **DEVICE:** Cytosorb

## Key facts

- **NCT ID:** NCT04048434
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06
- **Primary completion:** 2023-09
- **Final completion:** 2024-09
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2021-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04048434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04048434, "Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04048434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*